Showing 261 - 280 results of 1,358 for search 'treating modification', query time: 0.10s Refine Results
  1. 261

    The METTL3/TGF-β1 signaling axis promotes osteosarcoma progression by inducing MSC differentiation into CAFs via m6A modification by Jin Qi, Sihang Liu, Baomin Wu, Gang Xue

    Published 2025-04-01
    “…Additionally, METTL3 was found to enhance the stability and expression of TGF-β1 mRNA through m6A modification, thereby facilitating the differentiation process of MSCs. …”
    Get full text
    Article
  2. 262
  3. 263

    Kinetics, equilibrium and thermodynamics studies on natural and heat treated clays for the removal of arsenate ions from aqueous solution by Ali El-Rayyes, Mohamed Hefnawy, Moamen S. Refat, Oyebola Elizabeth Ogunbamowo, Abidemi Mercy Babatimehin, Patrick T. Ngueagni, Edwin Andrew Ofudje, Amnah Mohammed Alsuhaibani

    Published 2025-05-01
    “…Abstract This study investigates the adsorption properties of arsenic (As(V)) from aqueous solutions using natural clay (NAC) and heat-treated natural clay (HTNAC), highlighting its novelty and significance as a sustainable approach to arsenic removal. …”
    Get full text
    Article
  4. 264
  5. 265
  6. 266
  7. 267

    PET/CT-derived coronary calcium score may predict cardiac complications in anthracycline-treated patients with lymphoma by Genevieve Douglas, Zoe Loh, Evonne S.Y. Shum, Sze-Ting Lee, Niamh Waters, Garry Hamilton, Geoffrey Chong, Alexandra C. Murphy, Eliza A. Hawkes

    Published 2025-02-01
    “…We enrolled 358 consecutive patients with lymphoma treated between 2012 and 2022, calculating the CACS from their pretreatment PET/CT. …”
    Get full text
    Article
  8. 268

    ALKBH1 knockdown promotes the growth, migration and invasion of HTR-8/SVneo cells through regulating the m5C modification PSMD14 by Caili Zhang, Jie Li, Luwen Wang, Peifeng Yang, Xiaohua Luo

    Published 2025-03-01
    “…Abstract Preeclampsia (PE) is a pregnancy disease characterized by insufficient invasion and growth of trophoblast cells. adeno-associated virus encoding alkB homolog 1 (ALKBH1) is a demethylase in 5-methylcytosine (m5C) methylation modification. This study was performed to explore the role of ALKBH1 in hypoxia treated human extravasated trophoblast cells. …”
    Get full text
    Article
  9. 269

    Impact of Molding Temperature, Fiber Loading and Chemical Modifications on the Physicomechanical, and Microstructural Morphology Properties of Woven Kenaf Fiber/PLA Composites for... by Jai Inder Preet Singh, Vikas Sharma, Sehijpal Singh, Vikas Dhawan, Ahmed Belaadi, Rajeev Kumar, Shubham Sharma, Abhinav Kumar, Fuad A. Awwad, M. Ijaz Khan, Emad A. A. Ismail

    Published 2024-12-01
    “…The consequences of processing variables such as fiber volume percent ranging from 25% to 50% and molding temperature range of 160°C to 180°C were also examined on the mechanical characteristics of developed composites and are validated using SEM analysis. Surface modifications result in improved tensile and flexural characteristics of developed treated kenaf/PLA composites. …”
    Get full text
    Article
  10. 270
  11. 271

    Compression force promotes the osteogenic differentiation of periodontal ligament stem cells by regulating NAT10-mediated ac4C modification of BMP2 by Yan Feng, Ting Zhang, Yue Chang

    Published 2024-12-01
    “…Methods Compressive force was used to treat PDLSCs to simulate orthodontic force treatment. …”
    Get full text
    Article
  12. 272
  13. 273
  14. 274

    Balloon and Glue Technique: A Modification of Distal Reinforcement to Prevent Anastomotic New Entry, Reducing Replacement Range in Acute Type A Aortic Dissection by Masato Furui, Go Kuwahara, Yuta Sukehiro, Hideichi Wada

    Published 2025-03-01
    “…Ten patients with acute type A aortic dissection were treated using this technique. Postoperative computed tomography indicated no evidence of distal anastomotic entry tears. …”
    Article
  15. 275
  16. 276
  17. 277
  18. 278

    Real-world palbociclib dose modifications and clinical outcomes in patients with HR+/HER2− metastatic breast cancer: A Flatiron Health database analysis by Rachel M. Layman, Xianchen Liu, Benjamin Li, Lynn McRoy, Adam Brufsky

    Published 2025-06-01
    “…Purpose: To examine the associations of palbociclib dose modifications with clinical outcomes of patients with HR+/HER2− metastatic breast cancer (MBC) treated with first-line (1L) palbociclib + aromatase inhibitor (AI) in routine practice. …”
    Get full text
    Article
  19. 279
  20. 280